NEXT BIG IDEA

Hudson Medical Research Institute

Supporting innovation and commercialisation across the full product lifecycleCortellis Competitive Intelligence

Amabel Tan, PhDLife Sciences Solutions Consultant, MelbourneAmabel.tan@clarivate.com

July 2017

2

cell based therapies in development (743 SC, 223 Umbilical SC and 365 T cell)

>1700

394

208

Clinical Biomarkers examined for Cerebral Palsy

Exosome-based patent inventions

With the ever growing number of therapies and inventions, it is critical to know what is out there and use this knowledge to differentiate your discovery

3

AGENDA

1. What is Cortellis Competitive Intelligence?

2. 3 Key Questions To Ask When Conducting Competitive Intelligence

3. Q&A

4

Discovery

PreclinicalClinical

Regulatory

Deals and Partnering Launch

Cortellis.IntelligenceToolSupportingInnovationFromDiscoverytoLaunch

Contentmodules

DRUGS&BIOL

66,707

COMPANIES

147,448

PATENTS6,685,519patents

groupedinto3,001,372families

DEALS

75,221

PRESSRELEASES

316,052

CONFERENCES63,857

reports/presentations

CLINICALTRIALSDrugs,biomarkers,MD

170,930

LITERATUREABSTRACTS

2,433,471

BROKERREPORTS

1,783,781

EVENTTRANSCRIPTS

69,401

VENTURECAPITALFIRMS

5,583

DISEASEBRIEFINGS

Health&EconomicBurden,Treatmentpipeline

157

Datacorrectasof1March2017

6

>3 Million Biomedical Patents with DWPI (Drugs, medical devices & diagnostics reformulations etc)-search by

• gene/protein target • patent type/technology• chemical structure

>60,000Global conferences

160,000 companies>80,000 deals-Benchmark comparable deals-Analyse trends by stage/indication/deal type

Manually curatedExpertly Indexed

Updated daily

Cortellis Competitive & Clinical trials Intelligence: From Discovery to Launch

>60,000 drugs/biologicsDiscovery-Clinical Trial-LaunchStructure searchingTarget-based actionPlatform/TechnologySWOTSales and Forecast

Clinical TrialsProtocolsBiomarkersIntervention

1. What is the competitive landscape for a disease, technology or target?-including size, trends, the leading products and companies, sales & forecasts?

Use case by technology: Umbilical cord stem cellsUse case by disease: Systemic Lupus Erythematosus

2. What are the opportunities/unmet need? What is the health/economic burden?

3. How novel and unique is this discovery? Is their potential IP? Is there a precedence for clinical use or relevance?

Use case: microRNA (prognostic)

Time PermittingUse case by target: Liver receptor homolog 1 (LRH-1/NR5A2)

3 Key questions to ask

EXTRA TIPS for logging inFor First time users1) Log into the Monash University Library page Cortellis via

Monash Libraryhttp://guides.lib.monash.edu/az.php?a=c&q=cortellis

2) REGISTER for Cortellis using your Monash email address (monash.edu). You will be sent a temporary password and you will be required reset your password.

3) For all future visits please enter via the Cortellis Login page as this will enable dotmatics, the chemical structure search tool to function. https://cortellis.thomsonreuterslifesciences.com/ngg/login.do?session=nosso

Want to Register For Cortellis Competitive Intelligence & Disease Briefings?

Amabel Tan & Jenny Vandine Mendoza| | Amabel.tan@tr.com | clarivate.com